rdf:type |
|
lifeskim:mentions |
umls-concept:C0001962,
umls-concept:C0019010,
umls-concept:C0022771,
umls-concept:C0024554,
umls-concept:C0042960,
umls-concept:C0150097,
umls-concept:C0201734,
umls-concept:C0871161,
umls-concept:C1280500,
umls-concept:C1549078,
umls-concept:C1997894,
umls-concept:C2353244
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-8-21
|
pubmed:abstractText |
Mirodenafil is a phosphodiesterase type 5 (PDE-5) inhibitor developed for the treatment of erectile dysfunction. Mirodenafil has the possibility of being administered with alcohol.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1879-114X
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1234-43
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:19695390-Adult,
pubmed-meshheading:19695390-Area Under Curve,
pubmed-meshheading:19695390-Blood Pressure,
pubmed-meshheading:19695390-Cross-Over Studies,
pubmed-meshheading:19695390-Drug Interactions,
pubmed-meshheading:19695390-Electrocardiography,
pubmed-meshheading:19695390-Ethanol,
pubmed-meshheading:19695390-Hemodynamics,
pubmed-meshheading:19695390-Humans,
pubmed-meshheading:19695390-Korea,
pubmed-meshheading:19695390-Male,
pubmed-meshheading:19695390-Phosphodiesterase 5 Inhibitors,
pubmed-meshheading:19695390-Phosphodiesterase Inhibitors,
pubmed-meshheading:19695390-Pyrimidinones,
pubmed-meshheading:19695390-Sulfonamides,
pubmed-meshheading:19695390-Time Factors,
pubmed-meshheading:19695390-Young Adult
|
pubmed:year |
2009
|
pubmed:articleTitle |
Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea.
|
pubmed:affiliation |
Department of Pharmacology and Clinical Pharmacology, Seoul National University College of Medicine and Hospital, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|